Posts by Mourabit Halima

Febrile neutropenia is a significant concern among immunocompromised patients due to the high infection-related mortality if left untreated. At the recent 4th Shanghai Symposium on Clinical Application of Autologous Hematopoietic Stem Cell Transplantation, Dr. Jie Xu of Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, discussed new empirical treatment approaches. This article consolidates the key points from her presentation.

From October 18 to 20, 2024, the 2024 Jiangsu Hematology Physicians Association Academic Conference was held in Taizhou, Jiangsu Province, focusing on the standardized diagnosis and treatment of hematologic diseases. Organized by the Jiangsu Hematology Physicians Association and hosted by the Affiliated Taizhou People’s Hospital of Nanjing Medical University and The First Affiliated Hospital of Nanjing Medical University (Jiangsu Provincial People’s Hospital), the conference provided a high-level academic exchange platform. Hematology Frontier invited Dr. Jianyong Li, Chairman of the conference and a distinguished expert from Jiangsu Provincial People’s Hospital, to share his insights on the event’s key highlights and discuss the current and future directions of hematology in China.

The 5th Tianjin International Lymphoma Academic Conference, as an academic platform to promote international academic exchange and cooperation, has actively played its role as a bridge, facilitating in-depth exchange and cooperation in the field of international lymphoma. During the conference, "Hematology Frontier" specially invited Professor Owen O’Connor, President of the Lymphoma Alliance and from the University of Virginia Cancer Center, and Professor Zhengzi Qian from the Tianjin Medical University Cancer Hospital to engage in a dialogue between China and the rest of the world, reviewing the current status and latest advances in the treatment of relapsed/refractory peripheral T-cell lymphoma (R/R PTCL).

Recently, the 11th Sino-French Hematology Academic Conference of the Chinese Medical Doctor Association was successfully held in Tianjin, attracting hundreds of domestic and international authoritative experts and scholars in the field of hematology. During the conference, "Hematology Frontier" specially invited Dr. Salomon Manier from the Hematology Department of Lille University Hospital in France to discuss the current treatment challenges, emerging treatment plans, and management in the elderly and frail patient population for patients with transplant-ineligible newly diagnosed multiple myeloma (TIE-NDMM).